The Effect of Cervical Stellate Ganglion Block Using Botulinum Toxin Type A in Intractable Cancer-related Pain: Case Report
Clinical Pain
; (2): 107-110, 2018.
Article
de Ko
| WPRIM
| ID: wpr-786709
Bibliothèque responsable:
WPRO
ABSTRACT
OBJECTIVE: For patients who do not relieve with pharmacological intervention, interventional treatment including neurolytic blocks may have a specific role in palliative cancer management.METHOD: We performed cervical stellate ganglion block for the second time with Botulinum toxin type A mixed with 4 ml of normal saline, total 75 IU of Botulinum toxin type A, minimal effective dosage was measured to minimize the possible side effects.RESULTS: About 3 days later, the patient reported that her continuous pain intensity had decreased from 8/10 to 4/10 on the visual analogue scale score. The frequency of the pain attack that required additional morphine injections was also decreased. As a result, her maximum morphine requirement dose per day was significantly reduced.CONCLUSION: In this case, cervical stellate ganglion block with Botulinum toxin hadlonger lasting effect in the continuous pain intensity and resulted in less frequent pain attack. Botulinum toxin can be a possibleintervention material in intractable neuropathic pain related to cancer.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Ganglion cervicothoracique
/
Toxines botuliniques
/
Toxines botuliniques de type A
/
Méthodes
/
Morphine
/
Névralgie
Limites du sujet:
Humans
langue:
Ko
Texte intégral:
Clinical Pain
Année:
2018
Type:
Article